Masimo activist Politan reveals proxy fight plan, letter
Founder and CEO of Masimo, Joe Kiani addresses a press conference in Bangalore on January 2, 2017. Manjunath Kiran | AFP | Getty Images Despite voting for change at last …
Founder and CEO of Masimo, Joe Kiani addresses a press conference in Bangalore on January 2, 2017. Manjunath Kiran | AFP | Getty Images Despite voting for change at last …
Plant-based meat alternatives, despite being ultraprocessed, may be healthier for the heart than meat, a new report suggests. Angela Weiss | AFP | Getty Images Plant-based meat alternatives, despite being …
Close-up of a yellow-fever mosquito biting human skin, it’s a culicidae vector of malaria, yellow fever, chikungunya, dengue and zika virus in Brazil, known locally as mosquito da dengue. Joao …
Starbucks on Tuesday launched a drink at stores nationwide called Iced Energy, which has up to 205 milligrams of caffeine in it — about the same amount as six cans …
Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, …
Independent Presidential candidate Robert F. Kennedy Jr. speaks during a campaign rally at Legends Event Center on December 20, 2023 in Phoenix, Arizona. Rebecca Noble | Getty Images The Supreme Court on …
The Food and Drug Administration on Friday authorized the first menthol-flavored electronic cigarettes for adult smokers, acknowledging that vaping flavors can reduce the harms of traditional tobacco smoking. The FDA said …
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing disorder and expects regulators to make a …
Neurotech startup Paradromics will be putting its brain implant on trial next year, as the race to be the leader in the nascent brain-computer interface space heats up. “The brain …
Gilead‘s experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday. None of the roughly 2,000 women in the trial who received the …